Anika Therapeutics, Inc. (ANIK)
19.10
-0.26
(-1.34%)
USD |
NASDAQ |
Oct 02, 16:00
19.12
+0.02
(+0.10%)
After-Hours: 20:00
Anika Therapeutics Market Cap : 255.62M for Oct. 2, 2026
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| October 02, 2026 | 255.62M |
| October 01, 2026 | 259.09M |
| September 30, 2026 | 263.11M |
| September 29, 2026 | 266.92M |
| September 28, 2026 | 276.76M |
| September 25, 2026 | 272.61M |
| September 24, 2026 | 270.74M |
| September 23, 2026 | 272.68M |
| September 22, 2026 | 279.57M |
| September 21, 2026 | 277.03M |
| September 18, 2026 | 278.50M |
| September 17, 2026 | 281.44M |
| September 16, 2026 | 278.90M |
| September 15, 2026 | 279.84M |
| September 14, 2026 | 283.59M |
| September 11, 2026 | 279.17M |
| September 10, 2026 | 280.91M |
| September 09, 2026 | 279.44M |
| September 08, 2026 | 281.58M |
| September 04, 2026 | 278.50M |
| September 03, 2026 | 281.04M |
| September 02, 2026 | 288.40M |
| September 01, 2026 | 282.52M |
| August 31, 2026 | 279.30M |
| August 28, 2026 | 282.38M |
| Date | Value |
|---|---|
| August 27, 2026 | 278.90M |
| August 26, 2026 | 290.14M |
| August 25, 2026 | 286.40M |
| August 24, 2026 | 285.59M |
| August 21, 2026 | 291.48M |
| August 20, 2026 | 285.59M |
| August 19, 2026 | 284.52M |
| August 18, 2026 | 288.67M |
| August 17, 2026 | 287.33M |
| August 14, 2026 | 287.73M |
| August 13, 2026 | 283.32M |
| August 12, 2026 | 294.83M |
| August 11, 2026 | 284.12M |
| August 10, 2026 | 276.76M |
| August 07, 2026 | 286.66M |
| August 06, 2026 | 269.80M |
| August 05, 2026 | 256.82M |
| August 04, 2026 | 262.44M |
| August 03, 2026 | 277.50M |
| July 31, 2026 | 258.02M |
| July 30, 2026 | 241.83M |
| July 29, 2026 | 216.40M |
| July 28, 2026 | 202.75M |
| July 27, 2026 | 201.01M |
| July 24, 2026 | 199.69M |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Market Cap Benchmarks
| Precigen, Inc. | 3.057B |
| Repligen Corp. | 10.25B |
| Amgen, Inc. | 217.88B |
| Biogen, Inc. | 32.48B |
| BioMarin Pharmaceutical, Inc. | 11.07B |
Market Cap Related Metrics
| PS Ratio | 2.230 |
| Price to Book Value | 1.862 |
| Price to Free Cash Flow | 478.66 |
| Price | 19.10 |
| Earnings Yield | -1.44% |